The results showed that MLXIPL was highly expressed in HCC tissues and cells, where it promoted the proliferation of HCC cells and inhibited its apoptosis, demonstrating that MLXIPL is an oncogene for prognosis in HCC. The gene discussed is MLXIPL; the disease is hepatocellular carcinoma.